Physician profile
Kyle Cannady
NPI 1457733826
$835.96
in general payments reported to CMS, 2019-2025
12 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $137 · 2023: $60.47 · 2024: $352 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $371.65 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $120.15 | 2022-2024 | Farxiga, Flumist Quadrivalent |
| Lilly USA, LLC | $68.89 | 2024-2025 | Zepbound, Mounjaro |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $52.53 | 2024-2025 | Caplyta |
| Glaxosmithkline, LLC. | $46.69 | 2024 | Arexvy, Trelegy Ellipta, Bexsero |
| Pfizer INC. | $45.31 | 2023-2024 | |
| Abbott Laboratories | $41.23 | 2022-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $27.27 | 2022-2024 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $18.70 | 2024 | |
| Sanofi-Aventis U.S. LLC | $16.94 | 2022 | |
| Exact Sciences Corporation | $13.89 | 2024 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $12.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Cannady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.